Possible side effects include increased heart rate and blood pressure, insomnia and nervousness. This medication slows down how quickly your stomach empties. This medication is also helpful if you have substance use disorder or if your main issue is sugar cravings. Bupropion-naltrexone combines an antidepressant (bupropion) and an addiction treatment drug (naltrexone). Semaglutide and Tirzepatide – Market Insights (Jenstrele et.al.,2002).“Since the introduction of semaglutide, the landscape of weight management has transformed significantly.” Obesity and excess weight significantly raise the risk of chronic illnesses like diabetes, heart disease, high blood pressure, and certain cancers—the leading causes of death worldwide. Weight loss drugs are effective tools for those patients with obesity. In conclusion, losing weight using drugs is one of the modern objectives that are aimed at balancing people’s weight. Then, in 2024 Chamadia started reading about a new class of injectable drugs making headlines abroad. Semaglutide mimics a hormone that regulates appetite and blood sugar – essentially, it tells your brain you’re full. By 2050, 450 million adults in India are projected to be overweight, according to an estimate in medical journal The Lancet. Jefferies, the investment bank, describes it as a “magic pill moment” for India, projecting that the semaglutide market could grow to $1 billion. It’s a key ingredient in Novo Nordisk’s wildly popular injectable weight-loss drug Ozempic. Is India about to make Ozempic-like weight-loss drugs a whole lot cheaper? You should only use weight loss drugs if you plan on keeping regular checkups with your healthcare provider. The decision to begin weight loss drugs should only happen after you and your provider discuss your health history. In November 2023, the FDA approved Zepbound injection for chronic weight management in adults with obesity, based on clinical evidence demonstrating significant weight loss outcomes (FDA News Release). Weight loss medications help with weight loss. “The management of obesity comes as a package; semaglutide is just one tool,” said Dr. Atul Luthra, endocrinologist at Fortis Hospital, near the capital New Delhi. A boom in weight-loss drug sales has transformed Eli Lilly into a Wall Street heavyweight, its stock up more than 35% this year and its market value recently crossing $1 trillion. Semaglutide, administered via subcutaneous injection, received FDA approval in December 2017 under the brand name Ozempic for the treatment of type 2 diabetes. Researchers made minor structural modifications to liraglutide to develop semaglutide, resulting in greater effectiveness and enabling once-weekly dosing. Projections indicate that by 2030, almost 64 million Indians will live with obesity, which will place India third in the world after the U.S. and China (Singh et.al.,2023). According to the National Family Health Survey-5 (NFHS-5), one in every four Indians is now overweight or obese (Figure 1) (Kalra et al., 2023). Weight loss medicines should always be taken under your provider’s supervision.According to the National Family Health Survey-5 (NFHS-5), one in every four Indians is now overweight or obese (Figure 1) (Kalra et al., 2023).Losing weight can feel like an uphill battle.This combination drug helps with weight loss by decreasing your appetite and helping you burn calories.This medication can also help with Type 2 diabetes because it helps manage blood sugar levels.The intestine produces natural hormones called incretins that help control blood sugar levels and appetite.In the future, more weight loss drugs should be invented since the number of obese patients is increasing worldwide.Obesity and excess weight significantly raise the risk of chronic illnesses like diabetes, heart disease, high blood pressure, and certain cancers—the leading causes of death worldwide. Global Obesity/Overweight Data Treatment Details Join hundreds of providers using Watchdoq or reach out for inquiries.For him, each delivery is more than a prescription refill – it’s a measure of progress, of finally gaining control over his health.Eli Lilly says it is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.This is a newer class of medications that were first used to treat Type 2 diabetes.Possible side effects include increased heart rate and blood pressure, insomnia and nervousness.Eli Lilly says India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being inadequately treated with suboptimal glycemic control.In November 2023, the FDA approved Zepbound injection for chronic weight management in adults with obesity, based on clinical evidence demonstrating significant weight loss outcomes (FDA News Release).Projections indicate that by 2030, almost 64 million Indians will live with obesity, which will place India third in the world after the U.S. and China (Singh et.al.,2023). Both medications require a prescription and medical oversight; with semaglutide’s patent set to expire in 2026, more affordable Indian generics are expected to enter the market (Figure 5). These medications help the pancreas release more insulin when blood sugar levels are high and reduce the release of glucagon, a hormone that raises blood sugar levels (Shankar et al., 2024). The Indian obesity drug market has expanded fivefold since 2021, reaching a value of ₹ 6.28 billion. Since then, the FDA has expanded its use for chronic obesity, enabling healthcare providers to prescribe it for weight loss. This blog provides a concise and insightful overview of how new weight loss drugs in India are transforming obesity care in the country. In a significant move towards reducing the obesity and its related diseases in the country, India’s Central Drugs Standard Control Organization (CDSCO) approved tirzepatide as novel weight loss drug. Talk to your healthcare provider before buying weight loss supplements on your own. These drugs are for people who have health conditions stemming from obesity or overweight. Weight loss medications help you lose weight. “This is not only about weight loss,” Chamadia insists. For him, each delivery is more than a prescription refill – it’s a measure of progress, of finally gaining control over his health. And in a country where Bollywood stars and social media influencers heavily shape body image, doctors worry the drugs could be misused. Before switching, the doctor will check your blood sugar levels, weight changes, the timing of your last dose, and how well you handled the previous medication.“The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India.The Indian obesity drug market has expanded fivefold since 2021, reaching a value of ₹ 6.28 billion.Most people lose around 5% of their body weight after three to six months.Weight loss medications help with weight loss.Bupropion-naltrexone combines an antidepressant (bupropion) and an addiction treatment drug (naltrexone).Eli Lilly and Company (India) has launched Mounjaro in a single-dose vial after receiving marketing authorization from the Central Drugs Standard Control Organisation (CDSCO).Weight loss drugs are potent, effective, but they have side effects.“Obesity and diabetes are recognised as serious conditions linked to various life-limiting health complications, making effective and sustained treatment critical. Diabetes Drug for Weight Loss His blood sugar sometimes dips to 100, the unicorn number for diabetics, something he says has “never happened in his history of 25 years of diabetes.” It’s the core part of popular commercially available anti-obesity drugs like Ozempic, which is often sold pre-loaded into a syringe that patients self-inject with. Analysts there predict a price war that could drive the cost of some weight-loss drugs down by as much as 90 percent in India – and possibly in other countries too. Mounjaro may offer a new approach to metabolic health management, providing healthcare providers with an innovative option to treat these diseases,” says Manish Mistry, Senior Medical Director, Lilly India. These drugs bring hope to many individuals dealing with weight-related health concerns, especially when combined with lifestyle changes. Although semaglutide and tirzepatide have demonstrated considerable effectiveness in controlling diabetes and obesity, they do come with some disadvantages. Are there any over-the-counter weight loss medicines? That’s where weight loss medications come in. They aren’t as powerful or as well-studied as prescription weight loss medications. Other OTC weight loss medications are supplements. How do weight loss medications work? Doctors usually start tirzepatide at 2.5 mg per week and increase it to 5 mg after four weeks to improve tolerability, especially in people new to GLP-1 RAs. In contrast, Novo Nordisk’s Wegovy entered the market in late June, with just 1,788 units sold, generating ₹25.3 million in sales (Reuters,July 2025). Lilly’s Mounjaro (tirzepatide) has gained an early advantage. North America currently holds about 60% of the total market share, making it the leading regional contributor. It is important to note that Ozempic is not officially available in the Indian market. In response to this rising burden, the role of lifestyle interventions and the introduction of new weight loss drugs in India are gaining increasing attention as potential solutions.In contrast, Novo Nordisk’s Wegovy entered the market in late June, with just 1,788 units sold, generating ₹25.3 million in sales (Reuters,July 2025).“Whenever you have a surge in demand, especially with weight-loss drugs, there is bound to be misuse,” obesity specialist Dr. Rajiv Kovil told CNN.Losing weight isn’t always as simple as eating less and exercising more.Lilly’s Mounjaro (tirzepatide) has gained an early advantage.Most adults can expect to lose between 3% to 12% of their starting body weight after one year.“The management of obesity comes as a package; semaglutide is just one tool,” said Dr. Atul Luthra, endocrinologist at Fortis Hospital, near the capital New Delhi.Weight loss medications are relatively new. Before switching, the doctor will check your blood sugar levels, weight changes, the timing of your last dose, and how well you handled the previous medication. Reasons for switching may include better blood sugar control, more weight loss, fewer side effects, lower cost, or medicine shortages. In September 2019, the FDA approved the oral formulation of semaglutide, branded as Rybelsus, to help individuals with type 2 diabetes manage their blood glucose levels. The first GLP-1 RA drug for weight management, liraglutide, was approved by the U.S. It’s important to know the side effects of this medication before starting it. Alli is the only one that’s FDA‑approved and available over the counter (OTC). This medication comes as a pill you swallow. Cost and Accessibility Issues Get weekly healthcare updates, treatment guides, and insights directly in your inbox. She is passionate about using these technologies to improve healthcare. “Obesity and diabetes are recognised as serious conditions linked to various life-limiting health complications, making effective and sustained treatment critical. Obesity, a chronic relapsing disease, is a major risk factor for diabetes, is linked to over 200 health complications, including hypertension, dyslipidemia, coronary heart disease, and obstructive sleep apnea. “Our mission to making life better for people living with obesity and diabetes in India is reflected in our efforts to accelerate the introduction of innovative medicines. India has witnessed a significant increase in the rates of obesity in recent years. S&S Insider is a market research company that delivers evidence based strategies for clients seeking growth. Thus, they are will cannot withstand doing exercise as the best method of losing weight. The exercises include strength training with weights. It is related to Glucagon-like peptide-1 receptor agonists or semaglutide. With the changing lifestyle and modernization, millions of people and the young in particular have become prone to obesity and overweight along with the consequences like chronic liver disease, diabetes in extremely affected individuals. Cleveland Clinic uses the expertise of many specialists to provide personalized medical weight management care. If you don’t, your provider may suggest a different medication or add another medication. The weight can come back if you stop the medication. Most adults can expect to lose between 3% to 12% of their starting body weight after one year. Healthcare providers also use body mass index (BMI) as a factor. Weight loss medicines should always be taken under your provider’s supervision. Losing weight isn’t always as simple as eating less and exercising more. “Regular physical activity and a proper diet not only improve the efficacy of semaglutide but also help with its tolerability. My insulin doses have come down, some of my other diabetes medicines have reduced.” There are side effects and risks of taking weight loss drugs.It’s a snapshot of India’s uneasy relationship with health and indulgence – and the backdrop to a fast-growing medical and commercial frenzy.Semaglutide remains the leading player in the global GLP-1 obesity drug market, accounting for approximately 60.7% of total revenue in 2024, as reported by Grand View Research.They’ll need to monitor your weight loss and make sure it’s still safe for you to take the medication.It’s important to know the side effects of this medication before starting it.Jefferies, the investment bank, describes it as a “magic pill moment” for India, projecting that the semaglutide market could grow to $1 billion.Get weekly healthcare updates, treatment guides, and insights directly in your inbox. The launch of Mounjaro demonstrates our ongoing support to this mission and our shared vision of a healthier nation.” Lilly is committed to collaborating with the government and industry to promote awareness and improve the prevention and management of these diseases,” says Winselow Tucker, President and General Manager, Lilly India. Eli Lilly and Company (India) has launched Mounjaro in a single-dose vial after receiving marketing authorization from the Central Drugs Standard Control Organisation (CDSCO). Many weight loss drugs are injections, but some are pills you swallow.He is already urging his 38-year-old son, who is also struggling with obesity and diabetes, to join him in injecting appetite-suppressing drugs.Novo Nordisk achieved another milestone in June 2021, when the FDA approved Wegovy for the treatment of obesity in adults.Its CEO Erez Israeli said he expects the generic drug to generate “hundreds of millions of dollars” in sales for the company.Subsequently, three months later, in June 2025, Novo Nordisk unveiled its blockbuster weight-loss drug, Wegovy, in India.Most weight loss medicines are prescription only.In a significant move towards reducing the obesity and its related diseases in the country, India’s Central Drugs Standard Control Organization (CDSCO) approved tirzepatide as novel weight loss drug. Its CEO Erez Israeli said he expects the generic drug to generate “hundreds of millions of dollars” in sales for the company. Rival firm Dr. Reddy’s told Reuters it plans to launch the generic version of semaglutide in 87 countries, including India, next year. That frenzy is over the imminent expiry of a patent protecting semaglutide, a protein that mimics a hormone telling your brain that you’re not hungry. It’s a snapshot of India’s uneasy relationship with health and indulgence – and the backdrop to a fast-growing medical and commercial frenzy. Yes, you can safely switch between semaglutide and tirzepatide with your doctor’s guidance. As a result, tirzepatide generally offers a ₹3,000–₹6,000 monthly cost advantage over semaglutide at similar dosage levels. This prolongs the feeling of fullness and helps prevent sharp spikes in blood sugar after meals (Moiz, Areesha et.al.,2025). GLP-1 RAs Work by mimicking the Action of a Natural Hormone Called GLP-1, which is produced in the small intestine and plays a key role in controlling blood sugar levels and appetite (Figure 3). In response to this rising burden, the role of lifestyle interventions and the introduction of new weight loss drugs in India are gaining increasing attention as potential solutions. In the future, more weight loss drugs should be invented since the number of obese patients is increasing worldwide. They’ll need to monitor your weight loss and make sure it’s still safe for you to take the medication. This medication can also help with Type 2 diabetes because it helps manage blood sugar levels. Your healthcare provider can help you understand the pros and cons of this treatment and if it’s right for you. Risk of Pancreatitis Your healthcare provider can help you understand the pros and cons of this treatment and if it’s right for you.Talk to your healthcare provider before buying weight loss supplements on your own.These drugs can be the answer to years of health challenges for many people.Weight loss medications help you lose weight.They aren’t as powerful or as well-studied as prescription weight loss medications.Healthcare providers also use body mass index (BMI) as a factor.It is important to note that Ozempic is not officially available in the Indian market.The launch of Mounjaro demonstrates our ongoing support to this mission and our shared vision of a healthier nation.”The shift could also be transformative for India, currently the world’s diabetes capital and among the fastest-growing markets on the planet for anti-obesity treatments and drugs. There are some risks involved with taking these drugs. It can raise blood pressure, so your provider will need to check yours regularly. This is a newer class of medications that were first used to treat Type 2 diabetes. Most weight loss medicines are prescription only. Talk to your provider so you know exactly how they work and how to use them. But these medications have risks and side effects. Sometimes, eating healthy and exercising isn’t enough. Losing weight can feel like an uphill battle. You should also make sure you check in with your provider regularly so they can monitor your progress. Lilly is committed to collaborating with the government and industry to promote awareness and improve the prevention and management of these diseases,” says Winselow Tucker, President and General Manager, Lilly India.There are some risks involved with taking these drugs.Analysts there predict a price war that could drive the cost of some weight-loss drugs down by as much as 90 percent in India – and possibly in other countries too.Since then, the FDA has expanded its use for chronic obesity, enabling healthcare providers to prescribe it for weight loss.The first GLP-1 RA drug for weight management, liraglutide, was approved by the U.S.This medication slows down how quickly your stomach empties.Both medications require a prescription and medical oversight; with semaglutide’s patent set to expire in 2026, more affordable Indian generics are expected to enter the market (Figure 5).If you don’t, your provider may suggest a different medication or add another medication. Weight loss drugs are potent, effective, but they have side effects. Short-term weight loss Chronic weight management Long-term weight loss India’s Health Silk Road initiative takes a new momentum with this approval in Indian healthcare system that addresses to more than 1.3 million population of India. Medical Pharma Lifestyle Pulse Semaglutide remains the leading player in the global GLP-1 obesity drug market, accounting for approximately 60.7% of total revenue in 2024, as reported by Grand View Research. According to a 2025 GlobeNewswire report, the global anti-obesity drug market is expected to grow from $12.8 billion in 2024 to $104.9 billion by 2035. Novo Nordisk achieved another milestone in June 2021, when the FDA approved Wegovy for the treatment of obesity in adults. Many weight loss drugs are injections, but some are pills you swallow. There are side effects and risks of taking weight loss drugs. The shift could also be transformative for India, currently the world’s diabetes capital and among the fastest-growing markets on the planet for anti-obesity treatments and drugs. The blockbuster drug, launched in the US a couple of years ago, is forecasted to reach global sales of $27 billion by 2029, overtaking Novo Nordisk‘s Ozempic (semaglutide) in the same weight loss market. Join hundreds of providers using Watchdoq or reach out for inquiries. As of 2023, adult obesity prevalence in India stood at around 6.5%, affecting nearly 100 million people. Eli Lilly says India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being inadequately treated with suboptimal glycemic control. Most people lose around 5% of their body weight after three to six months. If you’re doing well on the medicine, your provider may suggest you stay on it for years. That’s why developing healthy eating and exercise habits should be part of your treatment plan, too. The main benefit is that it helps you lose weight. Weight loss medications are relatively new. Phentermine as a standalone weight loss medication (Adipex-P) is for short-term use only.Obesity, a chronic relapsing disease, is a major risk factor for diabetes, is linked to over 200 health complications, including hypertension, dyslipidemia, coronary heart disease, and obstructive sleep apnea.You should also make sure you check in with your provider regularly so they can monitor your progress.The launch of semaglutide and tirzepatide in India represents a Pivotal Moment in the Management of Obesity in Healthcare.Doctors usually start tirzepatide at 2.5 mg per week and increase it to 5 mg after four weeks to improve tolerability, especially in people new to GLP-1 RAs.India has witnessed a significant increase in the rates of obesity in recent years.This marks the first-ever therapy approved for MASH, opening a new chapter in liver disease management and offering hope to millions at risk of progression to cirrhosis.This medication is also helpful if you have substance use disorder or if your main issue is sugar cravings.This blog provides a concise and insightful overview of how new weight loss drugs in India are transforming obesity care in the country.It can raise blood pressure, so your provider will need to check yours regularly. Semaglutide and Tirzepatide remain the key drugs propelling this growth. Subsequently, three months later, in June 2025, Novo Nordisk unveiled its blockbuster weight-loss drug, Wegovy, in India. The intestine produces natural hormones called incretins that help control blood sugar levels and appetite. In 2025, health authorities revised the definition of obesity for Asian Indians to reflect the higher risk of cardiometabolic diseases at lower BMI in South Asians. Ozempic is another widely popular medication used with diet and exercise to treat adults whose type 2 diabetes is not satisfactorily controlled. “The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India. Eli Lilly says it is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. Please always consult your healthcare provider to figure out whether these Treatments Are Suitable for Your Specific Situation. Phentermine as a standalone weight loss medication (Adipex-P) is for short-term use only. This combination drug helps with weight loss by decreasing your appetite and helping you burn calories. These weight loss medications come in a pill you swallow. Because of this, some GLP-1s are now approved for weight loss, too. "Mounjaro is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus." This move positions Lilly ahead of rival Novo Nordisk, whose widely popular drug Ozempic belongs to the same category, as both companies compete in the rapidly growing Indian market. The launch of semaglutide and tirzepatide in India represents a Pivotal Moment in the Management of Obesity in Healthcare. This marks the first-ever therapy approved for MASH, opening a new chapter in liver disease management and offering hope to millions at risk of progression to cirrhosis. By March 2025, when Eli Lilly’s tirzepatide (sold under the brand name Mounjaro) hit Indian pharmacies, he was first in line. “I did not want to carry this heavy weight as I got older and older,” he told CNN. At 70 years old, Mahesh Chamadia had almost given up on the idea of losing weight. He is already urging his 38-year-old son, who is also struggling with obesity and diabetes, to join him in injecting appetite-suppressing drugs. “Whenever you have a surge in demand, especially with weight-loss drugs, there is bound to be misuse,” obesity specialist Dr. Rajiv Kovil told CNN. At least 10 Indian firms, including Dr. Reddy’s Laboratories, Cipla, and OneSource Specialty Pharma have started processes to manufacture semaglutide weight-loss drugs, according to documents reviewed by CNN. India’s apex drug regulating authority approved 19 new drugs in the year 2024, including Eli Lillys' Mounjaro (tirzepatide) injection. Healthcare providers noticed that it also led to significant weight loss. Weight loss drugs work in different ways to help you lose weight. These drugs can be the answer to years of health challenges for many people. It’s important to discuss these with your healthcare provider.